Rathbones Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-3,965
Closed -$220K 312
2015
Q4
$220K Hold
3,965
0.01% 260
2015
Q3
$250K Hold
3,965
0.02% 250
2015
Q2
$290K Hold
3,965
0.02% 252
2015
Q1
$259K Hold
3,965
0.02% 268
2014
Q4
$258K Hold
3,965
0.02% 262
2014
Q3
$238K Hold
3,965
0.02% 265
2014
Q2
$275K Buy
+3,965
New +$257K 0.02% 240

Other funds holding STJ

Rathbones Group's STJ Position: Q1 2016 in Review

Rathbones Group sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 3,965 shares — an estimated $220K sold.

Rathbones Group first reported a position in STJ in Q2 2014 and held it in 7 quarters. The position peaked at $290K in Q2 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • Rathbones Group reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • Rathbones Group sold 3,965 St Jude Medical shares in Q1 2016, an estimated $220K.
  • Rathbones Group first reported a position in St Jude Medical in Q2 2014 and held it in 7 quarters.
  • Rathbones Group's St Jude Medical position peaked at $290K in Q2 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Rathbones Group's 13F filing for Q1 2016, filed 8 Apr 2016.